Article Details

PR Newswire - Morningstar

Retrieved on: 2024-06-03 02:28:22

Tags for this article:

Click the tags to see associated articles and topics

PR Newswire - Morningstar. View article details on hiswai:

Excerpt

Different from monoclonal antibodies, IBI389 redirects T cells to tumor cells by binding both CLDN18.2 expressed on tumor cells and CD3 on T cells ...

Article found on: www.morningstar.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo